Figure 7.
Overall response in patients with IBS-C in 2 randomized, placebo-controlled trials comparing lubiprostone vs placebo. IBS-C, irritable bowel syndrome with constipation.
Adapted from Drossman DA et al. Aliment Pharmacol Ther. 2009;29(3):329-341.36